Terms: = Prostate cancer AND AFP, AFPD, FETA, HPAFP AND Treatment
31 results:
1. Tumour Marker Requisition Pattern in a Tertiary Care Centre of Eastern Nepal.
Niraula A; Gelal B; Chaudhari RK; Das BK; Lamsal M
Kathmandu Univ Med J (KUMJ); 2022; 20(80):422-426. PubMed ID: 37795716
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of the biological functions of endoplasmic reticulum stress in prostate cancer.
Cen S; Jiang D; Lv D; Xu R; Hou J; Yang Z; Wu P; Xiong X; Gao X
Front Endocrinol (Lausanne); 2023; 14():1090277. PubMed ID: 36967783
[TBL] [Abstract] [Full Text] [Related]
3. Lectin Affinity Chromatography for the Discovery of Novel cancer Glycobiomarkers: A Case Study with PSA Glycoforms and prostate cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract] [Full Text] [Related]
4. [Pathological features of primary extragonadal germ cell tumor of the prostate with small round blue cell morphology].
Gan HL; Wang QF
Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):108-113. PubMed ID: 33535304
[No Abstract] [Full Text] [Related]
5. [
Kunikowska J; Cieślak B; Gierej B; Patkowski W; Kraj L; Kotulski M; Zieniewicz K; Królicki L
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):883-892. PubMed ID: 32885272
[TBL] [Abstract] [Full Text] [Related]
6. Tumour markers and their utility in imaging of abdominal and pelvic malignancies.
Lahoud RM; O'Shea A; El-Mouhayyar C; Atre ID; Eurboonyanun K; Harisinghani M
Clin Radiol; 2021 Feb; 76(2):99-107. PubMed ID: 32861463
[TBL] [Abstract] [Full Text] [Related]
7. Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer.
Qi L; Liu S; Jiang Y; Lin JM; Yu L; Hu Q
Anal Chem; 2020 Mar; 92(5):3867-3873. PubMed ID: 32069024
[TBL] [Abstract] [Full Text] [Related]
8. Transcriptome Analysis of WHV/c-myc Transgenic Mice Implicates Cytochrome P450 Enzyme 17A1 as a Promising Biomarker for Hepatocellular Carcinoma.
Wang F; Huang J; Zhu Z; Ma X; Cao L; Zhang Y; Chen W; Dong Y
Cancer Prev Res (Phila); 2016 Sep; 9(9):739-49. PubMed ID: 27339169
[TBL] [Abstract] [Full Text] [Related]
9. Recombinant human alpha fetoprotein synergistically potentiates the anti-cancer effects of 1'-S-1'-acetoxychavicol acetate when used as a complex against human tumours harbouring afp-receptors.
Arshad NM; In LL; Soh TL; Azmi MN; Ibrahim H; Awang K; Dudich E; Tatulov E; Nagoor NH
Oncotarget; 2015 Jun; 6(18):16151-67. PubMed ID: 26158863
[TBL] [Abstract] [Full Text] [Related]
10. DNA vaccines, electroporation and their applications in cancer treatment.
Lee SH; Danishmalik SN; Sin JI
Hum Vaccin Immunother; 2015; 11(8):1889-900. PubMed ID: 25984993
[TBL] [Abstract] [Full Text] [Related]
11. [Immunoassay of nine serological tumor markers on hydrogel-based microchip].
Zubcova ZhI; Savvateeva EN; Butvilovskaia VI; Cybul'skaia MV; Chechetkin VR; Samokhina LO; Vinnitskiĭ LI; Maslennikov VV; Reznikov IuP; Zasedatelev AS; Rubina AIu
Bioorg Khim; 2013; 39(6):693-704. PubMed ID: 25696931
[TBL] [Abstract] [Full Text] [Related]
12. Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study.
Turgutalp K; Ozhan O; Helvacı I; Ata A; Arican A; Boztepe B; Kıykım A
Clin Chem Lab Med; 2013 Apr; 51(4):889-95. PubMed ID: 23314541
[TBL] [Abstract] [Full Text] [Related]
13. Haematogenous abdominal wall metastasis of differentiated, alpha-fetoprotein-negative hepatocellular carcinoma after previous antiandrogen therapy within a site of lipoma manifestation since childhood.
Zachau L; Zeckey C; Schlue J; Sander J; Meyer-Heithuis C; Winkler M; Klempnauer J; Schrem H
World J Surg Oncol; 2012 May; 10():98. PubMed ID: 22647077
[TBL] [Abstract] [Full Text] [Related]
14. Clinical application of tumour markers: a review.
Amayo AA; Kuria JG
East Afr Med J; 2009 Dec; 86(12 Suppl):S76-83. PubMed ID: 21591514
[TBL] [Abstract] [Full Text] [Related]
15. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract] [Full Text] [Related]
16. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract] [Full Text] [Related]
17. Proteomic prediction of disease outcome in cancer : clinical framework and current status.
Steinert R; von Hoegen P; Fels LM; Günther K; Lippert H; Reymond MA
Am J Pharmacogenomics; 2003; 3(2):107-15. PubMed ID: 12749728
[TBL] [Abstract] [Full Text] [Related]
18. Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer.
Ugrinska A; Bombardieri E; Stokkel MP; Crippa F; Pauwels EK
Q J Nucl Med; 2002 Jun; 46(2):88-104. PubMed ID: 12114872
[TBL] [Abstract] [Full Text] [Related]
19. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Canil CM; Tannock IF
Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
[TBL] [Abstract] [Full Text] [Related]
20. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract] [Full Text] [Related]
[Next]